Skip to content
Recall Observatory FDA recall evidence

Drug product

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

D-0295-2026

December 30, 2025

Class II

Product summary

Firm
Zydus Pharmaceuticals (USA) Inc
Event
Event 98227
Status
Ongoing
Classification
Class II
Quantity
22,896 bottles
Official record key
drug-enforcement:D-0295-2026

Official wording

Reason: Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Code information: Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027

Distribution pattern: US Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent